Congratulations to Tanveer Tabish – he has just published an article in Redox Biology: ‘Developing the Next Generation of Graphene-based Platforms for Cancer Therapeutics: the Potential Role of Reactive Oxygen Species’.
Graphene has a promising future in applications such as disease diagnosis, cancer therapy, drug/gene delivery, bio-imaging and antibacterial approaches owing to graphene’s unique physical, chemical and mechanical properties alongside minimal toxicity to normal cells, and photo-stability. However, these unique features and bioavailability of graphene are fraught with uncertainties and concerns for environmental and occupational exposure. Changes in the physicochemical properties of graphene affect biological responses including reactive oxygen species (ROS) production.